Questions for Module $9$

$1.$ How can CRM technology improve the process of qualifying leads in a B$2$B sales environment compared to a B$2$C environment, and what unique challenges might Laurs & Bridz Pharmaceuticals face when implementing this in the pharmaceutical industry?

$2.$ What are the crucial differences in the sales pipeline management features of CRM systems tailored for small businesses versus those designed for large enterprises, and how should Laurs & Bridz Pharmaceuticals consider these differences when selecting a CRM solution?

$3.$ How can integrating CRM and ERP systems enhance the efficiency and effectiveness of sales and marketing teams at Laurs & Bridz Pharmaceuticals, especially in regulatory compliance and data management?

$4.$ How can Laurs & Bridz Pharmaceuticals effectively identify and select its key accounts using CRM technology, and what specific CRM functionalities would be critical to support this process in the pharmaceutical industry?

$5.$ What are some best practices for implementing a successful Key Account Management $($KAM$)$ strategy, and how can CRM tools support these practices at Laurs & Bridz Pharmaceuticals, considering the regulatory environment and competitive landscape of the pharmaceutical industry?